For San Diego life sciences the fourth quarter of 2018 was the strongest of the year from a leasing perspective.
PHARMA: Drug Used to Reverse Antiplatelet Activity
PhaseBio’s stock jumped March 18 after the company’s lead drug candidate showed promise in an early-stage clinical study.
CV Sciences is cashing in on rising demand for cannabidiol, or CBD.
BIOTECH: Local Co. Gains Global Reach In Sales, Marketing
CureMatch, a San Diego-based software startup that helps oncologists identify treatment options for patients, recently landed a big corporate partner.
Former NuVasive CEO Gregory Lucier, GreatCall CFO Brian Berning and Chicago private equity firm GTCR are teaming up to start a new life sciences company in San Diego.
A Sharp HealthCare program that delivers palliative care at home captured the 2019 Hearst Prize.
CureMetrix got the U.S. Food and Drug Administration’s blessing to market software that flags which mammograms raise suspicions of breast cancer.
SD 500 recap: Magda Marquet is one of the architects of the local life science sector. She and her husband, Francois Ferre, co-founded Althea Technologies, which they built into the region’s largest contract manufacturer before selling it in 2014.
PhaseBio’s stock jumped March 18 after the San Diego-based company’s lead drug candidate showed promise in an early-stage clinical study.
SD 500 recap: David Hale is CEO of Hale BioPharma Ventures LLC, a private company focused on the formation and development of biotechnology, specialty pharma, diagnostic and medical device companies.
The USS Midway Foundation announced that it awarded $10,000 to the San Diego Center for Children. The donation helps further implement the center’s Empowered Families program to better respond to the needs of families with a child suffering from a mental, emotional, or behavioral disorder.
More than 20 participants took a shot at angel investing for the first time at the first San Diego Angel Conference.
Scripps Research stands to gain a royalty windfall from a drug candidate that slows brain atrophy in patients with multiple sclerosis.
Ambrx’s platforms have netted $10 million upfront in a collaboration with BeiGene Ltd.
SD 500 recap: Shelley Lyford leads West Health, a collection of organizations focused on seniors and aging, developed under philanthropists Gary and Mary West.